A recent study in several models of diabetes combined with a classical AD model, such as the APP/PS1 mouse, concludes from the cytokine profiles exhibited in each pathology that neuroinflammation may be the mechanism by which diabetes affects the pathology of AD [80]. The gene discussed is APP; the disease is Alzheimer disease.